Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties

[Expert Profile] Chen Keji, Chief Physician, Professor, Doctoral Supervisor, Academician of the Chinese Academy of Sciences, National Master of Chinese Medicine, is an authoritative expert in integrated traditional Chinese and Western medicine for cardiovascular diseases in China, working at Xiyuan Hospital, China Academy of Chinese Medical Sciences. He has long been dedicated to clinical diagnosis, treatment, and scientific research of integrated Chinese and Western medicine for coronary heart disease, hypertension, and heart failure, and is an important founder of modern integrated Chinese and Western medicine.
[Education & Career] Professor Chen Keji graduated from Fujian Medical College, later systematically studied traditional Chinese medicine and studied under multiple TCM masters, becoming one of China's first integrated Chinese and Western medicine experts. He has long served as Director of the Cardiovascular Disease Center at Xiyuan Hospital, China Academy of Chinese Medical Sciences. He was elected as an Academician of the Chinese Academy of Sciences in 1991, received the title of "National Master of Chinese Medicine" in 2022, and has held important academic positions including President of the Chinese Association of Integrative Medicine. He is an academic leader in the field of integrated Chinese and Western medicine in China.
[Areas of Expertise] Professor Chen specializes in integrated Chinese and Western medicine diagnosis and treatment of cardiovascular diseases such as coronary heart disease, myocardial infarction, hypertension, heart failure, and arrhythmia. He has profound expertise in the "activating blood circulation and resolving stasis" method for treating coronary heart disease, and the combined application of Chinese and Western medicine to optimize cardiovascular disease prevention and treatment. He excels at organically combining TCM syndrome differentiation with modern cardiovascular diagnosis and treatment techniques, helping numerous cardiovascular patients improve symptoms, reduce cardiovascular events, and improve quality of life.
[Academic Achievements & Industry Contributions] Professor Chen has led a series of evidence-based studies on blood-activating stasis-resolving treatment for coronary heart disease, systematically confirming the clinical efficacy of blood-activating stasis-resolving Chinese herbal compound formulas (such as the Xuefu Zhuyu Decoction series), with findings published in international authoritative journals and receiving the First Prize of the National Science and Technology Progress Award. He has led the development of Chinese integrated Chinese and Western medicine cardiovascular disease diagnosis and treatment guidelines, actively promoted the standardization and internationalization of integrated Chinese and Western medicine, and created multiple integrated Chinese and Western medicine cardiovascular diagnosis and treatment standards, making foundational contributions to the development of integrated Chinese and Western medicine in China.
[Clinical Practice & Outstanding Contributions] With decades of medical practice, Professor Chen has treated hundreds of thousands of cardiovascular patients, with significant clinical efficacy and deep patient trust. He has received multiple national awards, trained a large number of integrated Chinese and Western medicine leaders, and has been repeatedly invited to present at international academic conferences. He is a truly deserving authoritative expert in the field of integrated Chinese and Western medicine in China.
[Honors & Reputation] Professor Chen Keji serves as Director of the Cardiovascular Disease Center at Xiyuan Hospital, China Academy of Chinese Medical Sciences and Honorary President of the Chinese Association of Integrative Medicine, among other academic positions. He was elected as an Academician of the Chinese Academy of Sciences in 1991, received the title of "National Master of Chinese Medicine" in 2022, and has presided over national-level major projects including the National Key R&D Program. He is an authoritative expert in the field of integrated Chinese and Western cardiovascular medicine in China. He has led a series of evidence-based studies on blood-activating stasis-resolving treatment for coronary heart disease, with findings receiving the First Prize of the National Science and Technology Progress Award. He has led the development of Chinese integrated Chinese and Western medicine cardiovascular disease diagnosis and treatment guidelines, and created multiple integrated Chinese and Western medicine diagnosis and treatment standards. He has trained a large number of integrated Chinese and Western medicine leaders, and is one of the founders of integrated Chinese and Western medicine in China. He is deeply trusted by patients and respected by peers alike.
|